Clinical Trial Update: Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) [Phase 4]

View source ↗

Summary

This update reports the completion of the Phase 4 PSO-TOP trial evaluating strategies to optimise outpatient care for patients with mild to moderate psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Snippet

Sponsor: Kristian Reich, MD | Conditions: Mild to Moderate Psoriasis | Phase 4 | Status: COMPLETED